Longevity Health Holdings, Inc.
XAGE
$0.61
-$0.10-14.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3,994.31% | -- | -- | -99.45% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3,994.31% | -- | -- | -99.45% | -- |
| Cost of Revenue | 66,900.00% | -- | -- | -- | -- |
| Gross Profit | 2,422.50% | -- | -- | -- | -- |
| SG&A Expenses | 77.57% | 67.75% | -15.66% | 113.76% | 68.77% |
| Depreciation & Amortization | -5.53% | 2.13% | -22.03% | -22.41% | -10.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.23% | 46.13% | 207.63% | -32.13% | -19.07% |
| Operating Income | -55.99% | -9.16% | -202.37% | 33.09% | 19.89% |
| Income Before Tax | 42.91% | 57.62% | -11,266.29% | 68.22% | 37.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.91% | 57.62% | -10,173.03% | 68.22% | 37.76% |
| Earnings from Discontinued Operations | -- | -- | -100.00% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.91% | 53.96% | -128.96% | 74.89% | 37.76% |
| EBIT | -55.99% | -9.16% | -202.37% | 33.09% | 19.89% |
| EBITDA | -57.23% | -9.29% | -219.46% | 33.21% | 20.06% |
| EPS Basic | 67.39% | 64.52% | -132.51% | 77.72% | 96.81% |
| Normalized Basic EPS | 67.90% | 67.34% | -12,680.28% | 69.69% | 96.62% |
| EPS Diluted | 67.39% | 64.52% | -132.51% | 77.72% | 96.81% |
| Normalized Diluted EPS | 67.90% | 67.34% | -12,680.28% | 69.69% | 96.62% |
| Average Basic Shares Outstanding | 75.03% | 29.77% | -10.95% | 12.21% | 1,743.20% |
| Average Diluted Shares Outstanding | 75.03% | 29.77% | -10.95% | 12.21% | 1,743.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |